Business Context and Reporting Period
This Form 8-K filing by iSpecimen Inc. (ISPC) is dated February 13, 2026, with the report signed on February 18, 2026. The filing addresses the status of the Company's 2025 Annual Meeting of Stockholders, which was originally convened on December 31, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events regarding the Annual Meeting and contains no financial performance data.
Material Changes
The primary material event is the repeated failure to achieve a quorum at the Annual Meeting. The meeting was adjourned on December 31, 2025, January 23, 2026, and February 13, 2026, due to insufficient stockholder attendance. No changes have been made to the proposals originally described in the Proxy Statement filed on November 21, 2025.
Guidance, Outlook, and Risks
The Company intends to reconvene the Annual Meeting on March 13, 2026, at 9:00 a.m. Eastern Time. The record date for determining stockholders entitled to vote remains November 3, 2025. The filing highlights a governance risk where the inability to secure a quorum delays the voting on stockholder proposals.
Investor Verification Checklist
- Verify the specific proposals listed in the Proxy Statement filed on November 21, 2025, which remain pending.
- Confirm the Company's plan to secure a quorum for the March 13, 2026, reconvened meeting.
- Review the Company's recent communications to stockholders regarding the reasons for low attendance.
- Check for any subsequent filings if the March 13, 2026, meeting also fails to achieve a quorum.